Biallelic Mutations in MTPAP Associated with a Lethal Encephalopathy

Abstract

Background A homozygous founder mutation in MTPAP/TENT6, encoding mitochondrial poly(A) polymerase (MTPAP), was first reported in six individuals of Old Order Amish descent demonstrating an early-onset, progressive spastic ataxia with optic atrophy and learning difficulties. MTPAP contributes to the regulation of mitochondrial gene expression through the polyadenylation of mitochondrially encoded mRNAs. Mitochondrial mRNAs with severely truncated poly(A) tails were observed in affected individuals, and mitochondrial protein expression was altered.

Objective To determine the genetic basis of a perinatal encephalopathy associated with stereotyped neuroimaging and infantile death in three patients from two unrelated families.

Methods Whole-exome sequencing was performed in two unrelated patients and the unaffected parents of one of these individuals. Variants and familial segregation were confirmed by Sanger sequencing. Polyadenylation of mitochondrial transcripts and de novo synthesis of mitochondrial proteins were assessed in patient's fibroblasts.

Results Compound heterozygous p.Ile428Thr and p.Arg523Trp substitutions in MTPAP were recorded in two affected siblings from one family, and a homozygous p.Ile385Phe missense variant identified in a further affected child from a second sibship. Mitochondrial poly(A) tail analysis demonstrated shorter posttranscriptional additions to the mitochondrial transcripts, as well as an altered expression of mitochondrial proteins in the fibroblasts of the two siblings compared with healthy controls.

Conclusion Mutations in MTPAP likely cause an autosomal recessive perinatal encephalopathy with lethality in the first year of life.

Keywords

MTPAP - mitochondrial poly(A) polymerase - encephalopathy - lethal encephalopathy - calcification

^* These authors contributed equally.

• References

• 1 Crosby AH, Patel H, Chioza BA. , et al. Defective mitochondrial mRNA maturation is associated with spastic ataxia. Am J Hum Genet 2010; 87 (05) 655-660
• 2 Bratic A, Clemente P, Calvo-Garrido J. , et al. Mitochondrial polyadenylation is a one-step process required for mRNA integrity and tRNA maturation. PLoS Genet 2016; 12 (05) e1006028
• 3 Wilson WC, Hornig-Do HT, Bruni F. , et al. A human mitochondrial poly(A) polymerase mutation reveals the complexities of post-transcriptional mitochondrial gene expression. Hum Mol Genet 2014; 23 (23) 6345-6355
• 4 Martin NT, Nakamura K, Paila U. , et al. Homozygous mutation of MTPAP causes cellular radiosensitivity and persistent DNA double-strand breaks. Cell Death Dis 2014; 5: e1130
• 5 Chomyn A. In vivo labeling and analysis of human mitochondrial translation products. Methods Enzymol 1996; 264: 197-211
• 6 Hornig-Do HT, Montanari A, Rozanska A. , et al. Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations. EMBO Mol Med 2014; 6 (02) 183-193
• 7 Kirby DM, Thorburn DR, Turnbull DM, Taylor RW. Biochemical assays of respiratory chain complex activity. Methods Cell Biol 2007; 80: 93-119
• 8 Bai Y, Srivastava SK, Chang JH, Manley JL, Tong L. Structural basis for dimerization and activity of human PAPD1, a noncanonical poly(A) polymerase. Mol Cell 2011; 41 (03) 311-320
• 9 Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46 (03) 310-315
• 10 Itan Y, Shang L, Boisson B. , et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods 2016; 13 (02) 109-110
• 11 Temperley RJ, Wydro M, Lightowlers RN, Chrzanowska-Lightowlers ZM. Human mitochondrial mRNAs--like members of all families, similar but different. Biochim Biophys Acta 2010; 1797 (6-7): 1081-1085
• 12 Anderson S, Bankier AT, Barrell BG. , et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290 (5806): 457-465
• 13 Ojala D, Montoya J, Attardi G. tRNA punctuation model of RNA processing in human mitochondria. Nature 1981; 290 (5806): 470-474
• 14 Tomecki R, Dmochowska A, Gewartowski K, Dziembowski A, Stepien PP. Identification of a novel human nuclear-encoded mitochondrial poly(A) polymerase. Nucleic Acids Res 2004; 32 (20) 6001-6014
• 15 Levy S, Schuster G. Polyadenylation and degradation of RNA in the mitochondria. Biochem Soc Trans 2016; 44 (05) 1475-1482
• 16 Nagaike T, Suzuki T, Katoh T, Ueda T. Human mitochondrial mRNAs are stabilized with polyadenylation regulated by mitochondria-specific poly(A) polymerase and polynucleotide phosphorylase. J Biol Chem 2005; 280 (20) 19721-19727
• 17 Slomovic S, Schuster G. Stable PNPase RNAi silencing: its effect on the processing and adenylation of human mitochondrial RNA. RNA 2008; 14 (02) 310-323
• 18 Imagawa E, Fattal-Valevski A, Eyal O. , et al. Homozygous p.V116* mutation in C12orf65 results in Leigh syndrome. J Neurol Neurosurg Psychiatry 2016; 87 (02) 212-216